Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines

Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise, making it one of the most prevalent chronic liver disorders. MASLD encompasses a range of liver pathologies, from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) with inf...

Full description

Bibliographic Details
Main Authors:	Salvatore Pezzino, Tonia Luca, Mariacarla Castorina, Stefano Puleo, Saverio Latteri, Sergio Castorina
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	Life
Subjects:	dysfunctional hemostasis NAFLD MASLD adipokines coagulation platelet
Online Access:	https://www.mdpi.com/2075-1729/14/1/93

Similar Items

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
by: Allison Soto, et al.
Published: (2024-02-01)

Hibernation and hemostasis
by: Edwin L. De Vrij, et al.
Published: (2023-06-01)

Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area <sup>†</sup>
by: Tanmoy Mondal, et al.
Published: (2023-11-01)

Hemostasis – compendium for students
by: Martyna Kosmalska, et al.
Published: (2020-12-01)

Features of vascular-platelet and coagulation hemostasis in relation to parameters of macular blood fl ow in women with preeclampsia
by: O. V. Kolenko, et al.
Published: (2021-12-01)

Associating Appendicitis with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Novel Insight into an Unexpected Connection
by: Christoph Roderburg, et al.
Published: (2024-02-01)

Saturated Fat-Mediated Upregulation of IL-32 and CCL20 in Hepatocytes Contributes to Higher Expression of These Fibrosis-Driving Molecules in MASLD
by: Katharina Schilcher, et al.
Published: (2023-08-01)

SYSTEM OF HEMOSTASIS AND ATHEROGENESIS
by: A. A. Gromov, et al.
Published: (2016-09-01)

Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis
by: Mercy Halleluyah Periayah, et al.
Published: (2017-10-01)

DIABETES MELLITUS AND CARDIOVASCULAR COMPLICATIONS: FOCUS ON HEMOSTASIS
by: G. G. Petrik, et al.
Published: (2014-03-01)

Impact of stress on hemostasis: A review
by: Vladimir V. Salukhov, et al.
Published: (2023-05-01)

MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges
by: Anju G. S. Phoolchund, et al.
Published: (2024-01-01)

Modern view on hemostasis system: cell theory
by: I. V. Schastlivtsev, et al.
Published: (2019-10-01)

Roles of immune dysregulation in MASLD
by: Tingyu Dong, et al.
Published: (2024-01-01)

Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD)
by: Antonella Mosca, et al.
Published: (2024-01-01)

Features of coagulation hemostasis in patients with polytrauma
by: M.B. Vyshynska
Published: (2023-03-01)

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
by: Claudia Theys, et al.
Published: (2024-01-01)

Alterations in hemostasis associated with pregnancy in patients with glycemic disorders
by: Irina Arkad'evna Bondar', et al.
Published: (2013-06-01)

Comparison of instrumental methods of hemostasis research
by: K. V. Bossenko
Published: (2017-12-01)

Comparison of instrumental methods of hemostasis research
by: K. V. Bossenko
Published: (2017-12-01)

Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Raghu Ramanathan, et al.
Published: (2023-12-01)

From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
by: Ming-Lun Yeh, et al.
Published: (2023-10-01)

The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Iulia Minciuna, et al.
Published: (2024-02-01)

Correspondence on Editorial regarding “Identification of signature gene set as highly accurate determination of MASLD progression”
by: Sungju Jung, et al.
Published: (2024-04-01)

HYPERURICEMIA INFLUENCE ON THE STATE OF PLATELET HEMOSTASIS IN PATIENTS WITH STAGE II HYPERTENSION
by: M.S. Valigura
Published: (2017-07-01)

HYPERURICEMIA INFLUENCE ON THE STATE OF PLATELET HEMOSTASIS IN PATIENTS WITH STAGE II HYPERTENSION
by: M.S. Valigura
Published: (2018-09-01)

Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
by: Salvatore Pezzino, et al.
Published: (2023-04-01)

Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
by: Majid Mufaqam Syed-Abdul
Published: (2023-12-01)

Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression
by: Ming-Ling Chang, et al.
Published: (2020-11-01)

MASLD treatment—a shift in the paradigm is imminent
by: Mariana Verdelho Machado, et al.
Published: (2023-12-01)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
by: Vera Francisco, et al.
Published: (2022-08-01)

Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment
by: Feryal Savari, et al.
Published: (2024-04-01)

A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
by: Javier Martínez-Sanz, et al.
Published: (2023-12-01)

Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver diseaseResearch in context
by: Carlos Jose Pirola, et al.
Published: (2024-03-01)

Role of pyroptosis in hemostasis activation in sepsis
by: Chengrui Zhu, et al.
Published: (2023-01-01)

Computational models of hemostasis: Degrees of complexity
by: M. Anand, et al.
Published: (2022-06-01)

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences
by: Joo Hyun Oh, et al.
Published: (2024-04-01)

The double roles of T cell-mediated immune response in the progression of MASLD
by: Zigan Li, et al.
Published: (2024-04-01)

Hemostasis in Pre-Eclamptic Women and Their Offspring: Current Knowledge and Hemostasis Assessment with Viscoelastic Tests
by: Christos-Georgios Kontovazainitis, et al.
Published: (2024-02-01)

Peculiarities of coagulation hemostasis disorders in patients with chronic obstructive pulmonary disease.
by: V. H. Yakovlieva
Published: (2015-09-01)